Evidence map›Paper›PMID 24650575›Full record

ArticleThe international journal of neuropsychopharmacology2014

Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor.

Lisa M McFadden, Paula L Vieira-Brock, Glen R Hanson, Annette E Fleckenstein

Open access · bronzeAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lisa M McFaddenDepartment of Pharmacology and Toxicology,University of Utah,Salt Lake City, UT 84112,USA.
Paula L Vieira-BrockDepartment of Pharmacology and Toxicology,University of Utah,Salt Lake City, UT 84112,USA.
Glen R HansonDepartment of Pharmacology and Toxicology,University of Utah,Salt Lake City, UT 84112,USA.
Annette E FleckensteinDepartment of Pharmacology and Toxicology,University of Utah,Salt Lake City, UT 84112,USA.
University of Utah · US

Funding

Vmat AND NEUROTOXICITYP01DA013367 · NIDA · UNIVERSITY OF UTAH · PI GIBB, JAMES WOOLLEY · 2001 to 2012
$10.1M
Psychostimulants and Monoamine TransportersR01DA011389 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 2003 to 2012
$2.5M
Role of Neurotensin Systems in Methamphetamine Self AdministrationR01DA031883 · NIDA · UNIVERSITY OF UTAH · PI HANSON, GLEN R · 2012 to 2016
$1.5M
K02 ApplicationK02DA019447 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 2005 to 2014
$1.3M
Pharmacology and Toxicology of Methamphetamine Abuse (K05 DA00378)K05DA000378 · NIDA · UNIVERSITY OF UTAH · PI HANSON, GLEN R · 1998 to 2011
$1.2M
METHAMPHETAMINE AND DOPAMINE TRANSPORTERSR29DA011389 · NIDA · UNIVERSITY OF UTAH · PI FLECKENSTEIN, ANNETTE · 1998 to 2002
$329k
The effects of methamphetamine self-administration on hippocampal serotonergic syF32DA033097 · NIDA · UNIVERSITY OF UTAH · PI MCFADDEN, LISA M · 2012 to 2013
$106k
NIDA NIH HHS DA000378NIDA NIH HHS DA011389NIDA NIH HHS DA013367NIDA NIH HHS DA019447NIDA NIH HHS DA 031883NIDA NIH HHS DA033097NIDA NIH HHS F32 DA033097NIDA NIH HHS K02 DA019447NIDA NIH HHS K05 DA000378NIDA NIH HHS P01 DA013367NIDA NIH HHS R01 DA011389NIDA NIH HHS R01 DA031883
6 · The paper itself

Abstract

Preclinical studies suggest that prior treatment with escalating doses of methamphetamine (METH) attenuates the persistent deficits in hippocampal serotonin (5-hydroxytryptamine; 5HT) transporter (SERT) function resulting from a subsequent 'binge' METH exposure. Previous work also demonstrates that brain-derived neurotrophic factor (BDNF) exposure increases SERT function. The current study investigated changes in hippocampal BDNF protein and SERT function in rats exposed to saline or METH self-administration prior to a binge exposure to METH or saline. Results revealed that METH self-administration increased hippocampal mature BDNF (mBDNF) immunoreactivity compared to saline-treated rats as assessed 24 h after the start of the last session. Further, mBDNF immunoreactivity was increased and SERT function was not altered in rats that self-administered METH prior to the binge METH exposure as assessed 24 h after the binge exposure. These results suggest that prior exposure to contingent METH increases hippocampal mBDNF, and this may contribute to attenuated deficits in SERT function.

Indexed as

AnimalsBrain-Derived Neurotrophic FactorHippocampusMaleMethamphetamineRadionuclide ImagingRatsRNA-Binding ProteinsSelf AdministrationSerotoninSynaptosomesTritiumBrain-Derived Neurotrophic FactorMethamphetamineRNA-Binding ProteinsSerotoninSert1 protein, ratTritium

Identifiers

PMID24650575
PMCPMC4074226
OpenAlexW2021577912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.